Abstract
Ionotropic glutamate receptors (iGluRs) are large integral membrane multi-protein complexes that create ion channels in plasma membranes. Upon binding of receptor specific ligands (e.g., glutamate), increased efflux or influx of mono- or divalent cations (e.g., Ca2+) promotes synaptic transmission, cellular migration, and survival. Three classes of iGluRs were originally defined after their respective agonists: AMPA, kainate, and NMDA receptors (NMDARs). Recently, we examined iGluR families at the genetic level using Next-Generation Sequencing (NGS) (whole-exome sequencing (WES)) and discovered a high prevalence of somatic mutations within the gene for one of the NMDAR subunits, GRIN2A, specifically in malignant melanoma. Following confirmation of the somatic mutations, we focused on functional characterization of a subset of the GRIN2A mutants that demonstrated a loss of NMDAR functionality. We used gene expression and protein biochemistry to examine complex formation between GluN1 subunit (encoded by GRIN1) and GluN2A subunit (encoded by GRIN2A), anchorage-independent growth in soft agar and cellular migration. Furthermore, we used shRNA depletion of endogenous GRIN2A in melanoma cells expressing either wild-type GRIN2A or mutant GRIN2A and measured cellular proliferation compared to negative controls. Our data show that somatic mutation of certain residues in GluN2A results in increased survival and is the first such report to demonstrate the functional importance of GRIN2A mutations in melanoma and the significance ionotropic glutamate receptor signaling plays in malignant melanoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20(6):687–702. doi:10.1159/000110430
Prickett TD, Zerlanko BJ, Hill VK, Gartner JJ, Qutob N, Jiang J et al (2014) Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation. J Invest Dermatol 134(9):2390–2398. doi:10.1038/jid.2014.190
Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J et al (2011) Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43(5):442–446. doi:10.1038/ng.810
Coban A, Gundogdu G, Poyraz M, Yegen G, Demirtas-Tatlidede A et al (2015) NMDA receptor encephalitis with cancer of unknown primary origin. Tumori 102(Suppl 2). doi:10.5301/tj.5000447
Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N et al (2013) GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 45(9):1073–1076. doi:10.1038/ng.2727
Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M et al (2013) Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 45(9):1067–1072. doi:10.1038/ng.2728
Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405–496. doi:10.1124/pr.109.002451
Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P et al (2009) Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 41(5):518–520. doi:10.1038/ng.340
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Prickett, T.D., Gartner, J.J., Samuels, Y. (2017). Genetic and Functional Analysis of GRIN2A in Tumor Samples. In: Burnashev, N., Szepetowski, P. (eds) NMDA Receptors. Methods in Molecular Biology, vol 1677. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7321-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7321-7_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7320-0
Online ISBN: 978-1-4939-7321-7
eBook Packages: Springer Protocols